Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

7 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Evaluating Predictors of Immune-Related Adverse Events and Response to Checkpoint Inhibitors in Myeloid Malignancies.
Gesiotto QJ, Swoboda DM, Shallis RM, Al Ali N, Padron E, Kuykendall AT, Song J, Talati C, Sweet K, Lancet JE, Zeidan AM, Komrokji RS, Sallman DA. Gesiotto QJ, et al. Clin Lymphoma Myeloma Leuk. 2021 Jun;21(6):421-424.e2. doi: 10.1016/j.clml.2021.01.010. Epub 2021 Jan 20. Clin Lymphoma Myeloma Leuk. 2021. PMID: 33583730 No abstract available.
Marrow ring sideroblasts are highly predictive for TP53 mutation in MDS with excess blasts.
Swoboda DM, Kanagal-Shamanna R, Brunner AM, Cluzeau T, Chan O, Al Ali N, Montalban-Bravo G, Gesiotto QJ, Gavralidis A, Hunter AM, Lee JH, Kuykendall AT, Talati C, Sweet KL, Lancet JE, Padron E, Hussaini M, Song J, Garcia-Manero G, Komrokji RS, Sallman DA. Swoboda DM, et al. Among authors: gesiotto qj. Leukemia. 2022 Apr;36(4):1189-1192. doi: 10.1038/s41375-021-01486-w. Epub 2022 Jan 3. Leukemia. 2022. PMID: 34975158 No abstract available.
Novel therapies in myelodysplastic syndromes.
Swoboda DM, Gesiotto Q, Sallman DA. Swoboda DM, et al. Curr Opin Hematol. 2020 Mar;27(2):58-65. doi: 10.1097/MOH.0000000000000562. Curr Opin Hematol. 2020. PMID: 31972686 Review.